Healthcare product supply chains are changing. Some are getting longer, taking pharmaceuticals and medical devices further around the world to reach growing numbers of new patients in emerging markets. Others are getting shorter and more immediate, delivering products directly to patient homes or practitioners instead of the traditional destinations of hospitals or pharmacies.
FDA has approved LILETTA (levonorgestrel-releasing intrauterine system) from Actavis PLC for use by women to prevent pregnancy for up to three years. According to the company, LILETTA is placed in the uterus by a healthcare professional and works by continuously releasing levonorgestrel, a progestin, to prevent pregnancy.
A new plant-based package offered as an alternative to petroleum-based plastics is now available for personal care products, pharmaceuticals, and household goods. Offered by Earth Renewable Technologies, EarthBottle will launch at Engredea March 6 in Anaheim, CA, at booth 214.
Last week Mylan N.V. and Mylan Inc. reported that Mylan has completed the acquisition of Abbott Laboratories' non-U.S. developed markets specialty and branded generics business.
ORMOND BEACH, Fla., Feb. 24, 2015 /PRNewswire/ -- Command Medical Products, premier contract manufacturer of single use disposable plastic medical devices, today announced that Jim Carnall, Chief Operating Officer (COO), has been promoted to President with overall responsibility for Command Medical Products' facilities in both Florida and Nicaragua.
NEW BRUNSWICK, N.J., March 2, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced a binding offer from Cardinal Health to acquire its Cordis business for an aggregate value of $1.99 billion, consisting of $1.944 billion of cash proceeds from Cardinal Health plus approximately $46 million of retained net receivables. Cordis is a leader in the development and manufacture of interventional vascular technology with 2014 net revenue
PARSIPPANY, N.J., Feb. 25, 2015 /PRNewswire/ -- GlaxoSmithKline (GSK) Consumer Healthcare announced today the return of alli® (orlistat 60 mg capsules) to most stores in the U.S. and Puerto Rico since the voluntary retail recall of the product last spring. Replenished supplies of alli® feature improved tamper-evident packaging. alli® is the only FDA approved over-the-counter weight loss aid clinically proven to help boost weight loss efforts.
FDA concerns about aseptic and GMP practices at a manufacturer's site "potentially impacting product sterility" has prompted another recall this week.
Noxilizer Inc. reports that it has been approved for the CE marking of its RTS Series Sterilizers under the Medical Device Directive (MDD). The RTS series use room-temperature NO2 technology in a "rapid process that offers manufacturers significant technical and economic benefits over traditional sterilization methods," the company explains on its Web site.